Brain-Computer Interface
-
Musk’s Neuralink Aims for 20,000 Chip Implants Annually, Unveils Three Device Types
Neuralink, Elon Musk’s brain-computer interface company, plans a major expansion, aiming to implant BCI chips in 20,000 patients annually by 2031, generating $1 billion in revenue. The company intends to establish five clinics in six years, developing “Telepathy,” “Blindsight,” and “Deep” implants for communication, vision restoration, and neurological disorder treatment. US approval for “Telepathy” is expected by 2029, with “Blindsight” launching in 2030. Neuralink, valued at $9 billion, has secured $1.3 billion in funding.
-
Brain-Computer Interface National Standard Approved, Synchron and Waveless Holographic Anticipate Deepening Industry Applications
China is establishing national standards for non-invasive BCI medical devices, paralleling advancements in invasive BCI clinical trials. The BCI market is rapidly growing, with applications in healthcare, cognitive enhancement, and new human-computer interaction paradigms. Companies like Neuralink and Synchron are pushing boundaries, with widespread commercialization expected within five years. Micro-vision Holography is investing heavily in BCI, aiming to integrate it with robotics and quantum computing for diverse applications. BCIs are poised for significant growth and integration across multiple sectors.
